Get The Alerts + Report

TELA Bio, Inc. [TELA]

Reporting date: 10/09/2025

⚠️ Neutral Insider Buy Detected

📝 What Happened

  • Insider: Rocchio Betty Jo
  • Role: Director
  • Company: TELA Bio, Inc. (TELA)
  • Transaction Date(s): 2025-10-09
  • Table I (Non-Derivative Securities)
    • Sale : 11925
    • Average Sale Price: $0
    • Total Value: $0
    • Post-Transaction Direct Holdings: 11925
    • Indirect Holdings: 0
    • 10b5-1 Plan Used? No

📄 Summary

Rocchio Betty Jo, Director at TELA Bio, Inc. (TELA), acquired 11,925 shares (plus 17,550 underlying option shares) on October 9, 2025, at a reported price of $0.00, with total value not fully determinable. After the transaction, she now holds 11,925 direct shares and 17,550 derivative option shares. For retail traders, this is a neutral event: typical compensation grant, not an open-market purchase.

🔑 Interpretation

  • Type: Comp-related (equity compensation grants: restricted stock units and stock options)
  • Disposition: Shares/options were granted (not sold); they vest over time and are being held subject to vesting conditions
  • Size Context: Grant size (11,925 RSUs + 17,550 option shares) is consistent with director/employee compensation and does not by itself indicate large discretionary selling or purchases; appears to be routine compensation rather than profit-taking
  • ATH Metric: This filing shows grants with a $0 reported grant price (RSUs) and an option exercise price of $1.48. Because these are compensation awards (not open-market trades), their timing does not appear opportunistic relative to market highs/lows. Exact all-time high/low market levels are not included in this filing; based on the structure of the grants, there is no clear sign the awards were timed to an ATH or ATL.
  • Outlier Check: Nothing in this single filing suggests an unusually large or anomalous grant compared with typical equity compensation awards for directors; not an outlier based on available data

📊 Bullish or Bearish?

Neutral

Neutral. The filing reports acquisitions coded "A" (awarded/granted) for RSUs and options rather than open-market purchases or sales; these are compensation-related and subject to vesting, so they do not signal an immediate insider conviction to buy or sell. Cluster activity cannot be determined from this filing alone.

✅ Bottom Line (Retail Takeaway)

This transaction looks like routine equity compensation (RSUs and options) rather than a market-driven buy or sale. For retail traders, it is largely noise—unlikely to be a standalone trade signal unless corroborated by open-market purchases or coordinated insider activity from multiple senior executives.